Month: December 2012

CCSN Director Elaine Dean was interviewed by CTV News about the results of the ATLAS (Adjuvant Tamoxifen — Longer Against Shorter) study announced at the San Antonio Breast Cancer Symposium. This study found that ten years of adjuvant treatment with tamoxifen provided women with estrogen receptor-positive breast cancer greater protection against late recurrence and death from breast cancer compared with the current standard of five years of tamoxifen. The interview

Tiffany Glover, CCSN Policy & Public Affairs Manager, attended the Ontario Health Coalition (OHC) Assembly and Conference in Toronto on November 17-18, 2012. The discussion topic for the first day of the conference was protecting health care in the face of austerity, and included briefings on charting the electoral landscape, key issues and strategies of the political parties, opportunities and challenges under a minority government,